Torrent Pharmaceuticals Limited (TORNTPHARM) - Total Liabilities
Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has total liabilities worth Rs267.27 Billion INR (≈ $2.89 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TORNTPHARM net asset momentum to track the company's year-over-year net asset growth rate.
Torrent Pharmaceuticals Limited - Total Liabilities Trend (2005–2026)
This chart illustrates how Torrent Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. See TORNTPHARM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Torrent Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GF Securities Co Ltd
SHE:000776
|
China | CN¥943.99 Billion |
|
Api Group Corp
NYSE:APG
|
USA | $5.48 Billion |
|
LARGAN Precision Co Ltd
TW:3008
|
Taiwan | NT$39.76 Billion |
|
WOLTERS KLUWER ADR EO-12
F:WOS
|
Germany | €8.79 Billion |
|
Beijing Kingsoft Office Software In
SHG:688111
|
China | CN¥5.09 Billion |
|
Suncorp Group Ltd
AU:SUNPH
|
Australia | AU$19.54 Billion |
|
OMV AG ADR 1
F:OMVI
|
Germany | €21.37 Billion |
|
Coeur Mining Inc
NYSE:CDE
|
USA | $4.85 Billion |
Liability Composition Analysis (2005–2026)
This chart breaks down Torrent Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Torrent Pharmaceuticals Limited (TORNTPHARM) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Torrent Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Torrent Pharmaceuticals Limited (2005–2026)
The table below shows the annual total liabilities of Torrent Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs267.27 Billion ≈ $2.89 Billion |
+261.22% |
| 2025-03-31 | Rs73.99 Billion ≈ $800.17 Million |
-9.82% |
| 2024-03-31 | Rs82.04 Billion ≈ $887.28 Million |
-6.92% |
| 2023-03-31 | Rs88.14 Billion ≈ $953.20 Million |
+23.33% |
| 2022-03-31 | Rs71.47 Billion ≈ $772.91 Million |
-13.24% |
| 2021-03-31 | Rs82.37 Billion ≈ $890.85 Million |
-10.60% |
| 2020-03-31 | Rs92.15 Billion ≈ $996.52 Million |
-1.94% |
| 2019-03-31 | Rs93.97 Billion ≈ $1.02 Billion |
-2.33% |
| 2018-03-31 | Rs96.21 Billion ≈ $1.04 Billion |
+66.61% |
| 2017-03-31 | Rs57.74 Billion ≈ $624.48 Million |
+2.67% |
| 2016-03-31 | Rs56.24 Billion ≈ $608.23 Million |
+3.76% |
| 2015-03-31 | Rs54.20 Billion ≈ $586.16 Million |
+71.14% |
| 2014-03-31 | Rs31.67 Billion ≈ $342.50 Million |
+34.16% |
| 2013-03-31 | Rs23.61 Billion ≈ $255.28 Million |
+25.81% |
| 2012-03-31 | Rs18.76 Billion ≈ $202.91 Million |
+23.08% |
| 2011-03-31 | Rs15.24 Billion ≈ $164.86 Million |
+34.41% |
| 2010-03-31 | Rs11.34 Billion ≈ $122.66 Million |
+11.57% |
| 2009-03-31 | Rs10.17 Billion ≈ $109.94 Million |
+34.42% |
| 2008-03-31 | Rs7.56 Billion ≈ $81.79 Million |
+19.15% |
| 2007-03-31 | Rs6.35 Billion ≈ $68.64 Million |
+6.84% |
| 2006-03-31 | Rs5.94 Billion ≈ $64.25 Million |
+50.36% |
| 2005-03-31 | Rs3.95 Billion ≈ $42.73 Million |
-- |
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-int… Read more